Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taiwan Inabata Sangyo
Hsinchu, Taiwan
- Ownership
- Private
- Development stage
- Other
01
Overview
Taiwan Inabata Sangyo, a subsidiary of Inabata & Co., Ltd., is a trading company and regional distributor specializing in the supply of life science, chemical, functional materials, and pharmaceutical intermediates. It supports health, pharma, food, and agricultural sectors but does not engage in clinical-stage therapeutic development or proprietary R&D.
- Industry
- Chemicals & Materials
02
Partnerships
Sumitomo ChemicalPharmasynthese S.A.S.
Beyond the preview
Go deeper on Taiwan Inabata Sangyo.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Taiwan Inabata Sangyo.